Latest insights in therapeutic options for systemic right ventricular failure: a comparison with left ventricular failure

Research output: Contribution to journalArticleAcademicpeer-review

59 Citations (Scopus)


The number of adult patients with a systemic right ventricle (RV) is steadily increasing. Survival is relatively good in these patients, but deterioration of the systemic RV seems inevitable. Although therapeutic options for patients with LV failure are well established, their role in patients with systemic RV failure is often undefined. To appreciate the potency of LV failure therapy in patients with a systemic RV, insight into pathophysiology of systemic RV failure and into recent developments in therapeutic research are indispensible. This review provides these insights, and will facilitate and ameliorate therapeutic decision making in patients with a systemic RV.
Original languageUndefined/Unknown
Pages (from-to)960-963
Issue number12
Publication statusPublished - 2009

Cite this